Your browser doesn't support javascript.
loading
Biological perspective of thiazolide derivatives against Mpro and MTase of SARS-CoV-2: Molecular docking, DFT and MD simulation investigations.
Rasool, Nouman; Yasmin, Farkhanda; Sahai, Shalini; Hussain, Waqar; Inam, Hadiqa; Arshad, Arooj.
Afiliação
  • Rasool N; Center for Professional & Applied Studies, Lahore, Pakistan.
  • Yasmin F; Department of Biotechnology, Khawaja Fareed University of Science and Technology, Rahim Yar Khan, Pakistan.
  • Sahai S; Cloud Fusion Lab, Chicago, IL, United States.
  • Hussain W; Center for Professional & Applied Studies, Lahore, Pakistan.
  • Inam H; National Center of Artificial Intelligence, Punjab University College of Information Technology, University of the Punjab, Lahore, Pakistan.
  • Arshad A; Department of Life Sciences, University of Management and Technology, Lahore, Pakistan.
Chem Phys Lett ; 771: 138463, 2021 May 16.
Article em En | MEDLINE | ID: mdl-33716307
ABSTRACT
Humans around the globe have been severely affected by SARS-CoV-2 and no treatment has yet been authorized for the treatment of this severe condition brought by COVID-19. Here, an in silico research was executed to elucidate the inhibitory potential of selected thiazolides derivatives against SARS-CoV-2 Protease (Mpro) and Methyltransferase (MTase). Based on the analysis; 4 compounds were discovered to have efficacious and remarkable results against the proteins of the interest. Primarily, results obtained through this study not only allude these compounds as potential inhibitors but also pave the way for in vivo and in vitro validation of these compounds.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2021 Tipo de documento: Article